​

Merck (MRK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MRK Stock Forecast

Merck (MRK) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $128.54, with a high of $150.00 and a low of $100.00. This represents a 12.53% increase from the last price of $114.23.

$95 $106 $117 $128 $139 $150 High: $150 Avg: $128.54 Low: $100 Last Closed Price: $114.23

MRK Stock Rating

Merck stock's rating consensus is Buy, based on 36 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 24 Buy (66.67%), 11 Hold (30.56%), 1 Sell (2.78%), and 0 Strong Sell (0.00%).

Buy
Total 36 1 11 24 Strong Sell Sell Hold Buy Strong Buy

MRK Price Target Upside V Benchmarks

TypeNameUpside
StockMerck12.53%
SectorHealthcare Stocks 15.45%
IndustryDrug Manufacturers - General Stocks8.38%

Price Target Trends

1M3M12M
# Anlaysts21020
Avg Price Target$146.00$132.70$120.55
Last Closing Price$114.23$114.23$114.23
Upside/Downside27.81%16.17%5.53%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 2641511--30
Feb, 2621412--28
Jan, 2621512--29
Dec, 2521413--29
Nov, 2521313--28
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 12, 2026Mohit BansalWells Fargo$150.00$116.2229.07%31.31%
Feb 24, 2026Trung HuynhRBC Capital$142.00$123.9314.58%24.31%
Feb 13, 2026James ShinDeutsche Bank$150.00$121.5323.43%31.31%
Feb 04, 2026Asad HaiderGoldman Sachs$133.00$115.8614.79%16.43%
Feb 04, 2026BMO Capital$135.00$115.8616.52%18.18%
Feb 04, 2026Bernstein$100.00$115.86-13.69%-12.46%
Feb 03, 2026Scotiabank$136.00$116.3716.87%19.06%
Jan 27, 2026Cantor Fitzgerald$116.00$107.408.01%1.55%
Jan 08, 2026Wolfe Research$135.00$108.5924.32%18.18%
Jan 07, 2026UBS$130.00$110.9617.16%13.81%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 12, 2026Wells FargoOverweightOverweighthold
Feb 24, 2026RBC CapitalOutperforminitialise
Feb 19, 2026BarclaysOverweightOverweightinitialise
Feb 13, 2026Deutsche BankBuyBuyupgrade
Feb 04, 2026Goldman SachsBuyBuyhold
Feb 04, 2026BMO CapitalOutperformOutperformhold
Feb 04, 2026BernsteinMarket PerformMarket Performhold
Feb 04, 2026Wells FargoOverweightOverweighthold
Feb 03, 2026ScotiabankOutperformOutperformhold
Jan 27, 2026Cantor FitzgeraldNeutralNeutralhold

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.16$5.73$0.14$6.76$7.28---
Avg Forecast$5.79$7.39$1.38$7.76$9.23$10.03$10.74$10.74
High Forecast$5.96$7.71$1.46$7.87$10.03$11.36$12.56$11.28
Low Forecast$5.63$7.17$1.33$7.64$7.89$8.36$8.52$10.51
Surprise %-10.88%-22.46%-89.86%-12.89%-21.13%---

Revenue Forecast

$45B $52B $59B $66B $73B $80B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$48.70B$59.28B$60.12B$64.17B$65.01B---
Avg Forecast$48.52B$59.12B$59.97B$63.99B$67.11B$70.95B$74.43B$75.50B
High Forecast$49.59B$61.06B$60.30B$64.28B$68.80B$71.14B$74.90B$78.42B
Low Forecast$47.46B$57.78B$59.81B$63.75B$66.44B$70.77B$73.97B$74.24B
Surprise %0.38%0.27%0.24%0.28%-3.12%---

Net Income Forecast

$0 $7B $14B $21B $28B $35B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$13.05B$14.52B$365.00M$17.12B$18.25B---
Avg Forecast$12.27B$14.91B$365.00M$19.76B$21.95B$24.45B$26.84B$27.37B
High Forecast$14.72B$17.89B$438.00M$20.06B$25.55B$28.92B$32.00B$28.74B
Low Forecast$9.81B$11.93B$292.00M$19.46B$20.09B$21.30B$21.71B$26.77B
Surprise %6.36%-2.62%--13.37%-16.86%---

MRK Forecast FAQ

Is Merck stock a buy?

Merck stock has a consensus rating of Buy, based on 36 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 24 Buy, 11 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Merck is a favorable investment for most analysts.

What is Merck's price target?

Merck's price target, set by 36 Wall Street analysts, averages $128.54 over the next 12 months. The price target range spans from $100 at the low end to $150 at the high end, suggesting a potential 12.53% change from the previous closing price of $114.23.

How does Merck stock forecast compare to its benchmarks?

Merck's stock forecast shows a 12.53% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the drug manufacturers - general stocks industry (8.38%).

What is the breakdown of analyst ratings for Merck over the past three months?

  • March 2026: 13.33% Strong Buy, 50.00% Buy, 36.67% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 7.14% Strong Buy, 50.00% Buy, 42.86% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 6.90% Strong Buy, 51.72% Buy, 41.38% Hold, 0% Sell, 0% Strong Sell.

What is Merck’s EPS forecast?

Merck's average annual EPS forecast for its fiscal year ending in December 2026 is $10.03, marking a 37.77% increase from the reported $7.28 in 2025. Estimates for the following years are $10.74 in 2027, and $10.74 in 2028.

What is Merck’s revenue forecast?

Merck's average annual revenue forecast for its fiscal year ending in December 2026 is $70.95B, reflecting a 9.14% increase from the reported $65.01B in 2025. The forecast for 2027 is $74.43B, and $75.5B for 2028.

What is Merck’s net income forecast?

Merck's net income forecast for the fiscal year ending in December 2026 stands at $24.45B, representing an 33.93% increase from the reported $18.25B in 2025. Projections indicate $26.84B in 2027, and $27.37B in 2028.